PFG Advisors lowered its position in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 4.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,468 shares of the biotechnology company’s stock after selling 70 shares during the quarter. PFG Advisors’ holdings in Axon Enterprise were worth $872,000 as of its most recent SEC filing.
A number of other hedge funds also recently modified their holdings of AXON. Prestige Wealth Management Group LLC lifted its position in shares of Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after acquiring an additional 44 shares during the period. New Wave Wealth Advisors LLC bought a new stake in shares of Axon Enterprise in the 4th quarter worth approximately $40,000. Brooklyn Investment Group bought a new stake in shares of Axon Enterprise in the 3rd quarter worth approximately $41,000. Y.D. More Investments Ltd bought a new stake in shares of Axon Enterprise in the 4th quarter worth approximately $45,000. Finally, Planning Capital Management Corp lifted its position in shares of Axon Enterprise by 83.3% in the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after acquiring an additional 55 shares during the period. Institutional investors own 79.08% of the company’s stock.
Wall Street Analyst Weigh In
A number of analysts have commented on the company. The Goldman Sachs Group raised their price objective on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Barclays restated a “hold” rating on shares of Axon Enterprise in a research report on Monday. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $604.67.
Insiders Place Their Bets
In other news, President Joshua Isner sold 1,291 shares of the business’s stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $642.43, for a total transaction of $829,377.13. Following the completion of the sale, the president now owns 181,892 shares in the company, valued at $116,852,877.56. The trade was a 0.70 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $639.69, for a total value of $639,690.00. Following the sale, the director now owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. The trade was a 3.96 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 5,146 shares of company stock valued at $3,262,847. 6.10% of the stock is currently owned by corporate insiders.
Axon Enterprise Price Performance
Axon Enterprise stock opened at $534.56 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm has a market cap of $40.96 billion, a P/E ratio of 138.13, a P/E/G ratio of 5.17 and a beta of 1.12. The business’s fifty day moving average is $595.56 and its two-hundred day moving average is $532.90. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99.
Axon Enterprise Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
See Also
- Five stocks we like better than Axon Enterprise
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Utilities Stocks Explained – How and Why to Invest in Utilities
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- Energy and Oil Stocks Explained
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.